EAM
Eventide Asset Management’s Tourmaline Bio TRML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-320,916
| Closed | -$7.35M | – | 170 |
|
|
2024
Q1 | $7.35M | Buy |
+320,916
| New | +$7.35M | 0.12% | 130 |
|
|
2023
Q2 | – | Sell |
-156,109
| Closed | -$2.93M | – | 153 |
|
|
2023
Q1 | $2.93M | Hold |
156,109
| – | – | 0.05% | 133 |
|
|
2022
Q4 | $1.59M | Hold |
156,109
| – | – | 0.03% | 135 |
|
|
2022
Q3 | $4.11M | Hold |
156,109
| – | – | 0.08% | 125 |
|
|
2022
Q2 | $7.04M | Hold |
156,109
| – | – | 0.15% | 108 |
|
|
2022
Q1 | $15.4M | Hold |
156,109
| – | – | 0.24% | 97 |
|
|
2021
Q4 | $23.9M | Hold |
156,109
| – | – | 0.31% | 86 |
|
|
2021
Q3 | $20.7M | Hold |
156,109
| – | – | 0.27% | 93 |
|
|
2021
Q2 | $22.4M | Buy |
+156,109
| New | +$22.4M | 0.3% | 88 |
|